Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 20

Sort by

Sort Order Select

Journal Articles

An evolving understanding of low VWF and type 1 VWD

Nathan T. Connell

Blood (2024) 143 (14): 1324–1326.

https://doi.org/10.1182/blood.2023023488

Published: 2024

Journal Articles

Factor XIII subunits are stronger together

Nathan T. Connell

Blood (2024) 143 (5): 385–387.

https://doi.org/10.1182/blood.2023023039

Published: 2024

Journal Articles

Avatrombopag for Adults with Early Versus Chronic Immune Thrombocytopenia

Zain Virk, Rebecca Karp Leaf, David J Kuter, Katayoon Goodarzi, Nathan T. Connell, Jean M. Connors, Hanny Al-Samkari

Blood (2023) 142 (Supplement 1): 392.

https://doi.org/10.1182/blood-2023-179601

Published: 2023

Journal Articles

Evaluating the Impact of a Year-Long External Mentorship Pilot Program in Classical Hematology

Zoya Qureshy, Nathan T. Connell, Alfred I Lee, Allison A. King, Martina C Murphy, Erin G Reid, Soo Park

Blood (2022) 140 (Supplement 1): 1619–1620.

https://doi.org/10.1182/blood-2022-157669

Published: 2022

Journal Articles

Real-World Analysis of Healthcare Resource Utilization and Costs Among Patients Diagnosed with Von Willebrand Disease and Angiodysplasia

Nathan T. Connell, Jorge Caicedo, Natalia Nieto, Sagnik Chatterjee, Arunima Hait, Michael Bullano, Arun Gupta, Bob G Schultz

Blood (2022) 140 (Supplement 1): 7885–7886.

https://doi.org/10.1182/blood-2022-163760

Published: 2022

Journal Articles

Diversity, Equity, and Inclusion in Hematology and Oncology Fellowship Programs

Michael Mankbadi, Lidet Alemu, Afiya Bey, Nathan T. Connell, Lisa Fanning, Patricia Frustace, Inginia Genao, Janet Hafler, Ann S. LaCasce, Tiffany Lin Lucas, Ariela L. Marshall, Jodi Mones, Martina C Murphy, Rakhi P. Naik, Nikolai Podoltsev, Alfred Ian Lee

Blood (2021) 138 (Supplement 1): 2977.

https://doi.org/10.1182/blood-2021-145827

Published: 2021

Journal Articles

Anticoagulation Use and Outcomes Among Patients with Atrial Fibrillation and Von Willebrand Disease

Lauren E. Merz, Duaa AbdelHameid, Dareen M. Kanaan, Guohai Zhou, Peter M. Manzo, Nathan T. Connell

Blood (2021) 138 (Supplement 1): 590.

https://doi.org/10.1182/blood-2021-145803

Published: 2021

Journal Articles

Cost-Effectiveness of Long-Term Prophylaxis Versus on-Demand Treatment with Von Willebrand Factor Concentrate in Severe Inherited Von Willebrand Disease

Anushka Bhaskar, Nathan T. Connell, MDMPH

Blood (2020) 136 (Supplement 1): 4–5.

https://doi.org/10.1182/blood-2020-136241

Published: 2020

Journal Articles

Treatment of Acquired Hemophilia a with Rituximab and Emicizumab

Evan C. Chen, MD, William J. Gibson, MD PhD, Paula Temoczko, NP, Nathan T. Connell, MDMPH, Robert Handin, MD, Aric D. Parnes, MD

Blood (2020) 136 (Supplement 1): 18–19.

https://doi.org/10.1182/blood-2020-137262

Published: 2020

Journal Articles

Taken the wrong way, a complement becomes catastrophic

Nathan T. Connell

Blood (2020) 135 (4): 233–234.

https://doi.org/10.1182/blood.2019004337

Published: 2020

Journal Articles

Mentorship Experiences Among Second-Year U.S. Hematology/Oncology Fellows in the 2019 ASH Hematology/Oncology Fellows Survey

Alfred I Lee, MD PhD, Leah E Masselink, PhD, Emily Bass, Nathan T. Connell, MD MPH, Ariela L. Marshall, MD, Clese E Erikson, MPAff

Blood (2019) 134 (Supplement_1): 2124.

https://doi.org/10.1182/blood-2019-132252

Published: 2019

Journal Articles

Pregnancy Outcomes, Risk Factors, and Gestational Cell Count Trends in Pregnant Women with Essential Thrombocythemia and Polycythemia Vera

Chi-Joan How, MD, Orly Leiva, BS, Thomas Bogue, BS, Geoffrey Fell, MS, Mark Bustoros, MD, Nathan T. Connell, MD MPH, Jean M. Connors, MD, Irene M. Ghobrial, MD, Nancy Higgins, Nicholas A Jessop, David J. Kuter, Jennifer Lombardi Story, Ann Mullally, MD, Valentina Nardi, MD, Donna S Neuberg, ScD, Rachel Styles, BS, Jeffrey I. Zwicker, MD, Gabriela S. Hobbs, MD, Annemarie E Fogerty, MD

Blood (2019) 134 (Supplement_1): 4172.

https://doi.org/10.1182/blood-2019-127058

Published: 2019

Journal Articles

Fostamatinib for the treatment of chronic immune thrombocytopenia

Nathan T. Connell, Nancy Berliner

Blood (2019) 133 (19): 2027–2030.

https://doi.org/10.1182/blood-2018-11-852491

Published: 2019

Journal Articles

Ravulizumab: a complementary option for PNH

Nathan T. Connell

Blood (2019) 133 (6): 503–504.

https://doi.org/10.1182/blood-2018-12-891499

Published: 2019

Journal Articles

Pregnancy outcomes in inherited bone marrow failure syndromes

John M. Gansner, Maureen M. Achebe, Kathryn J. Gray, Revital Yefidoff-Freedman, Elena Labovitis, Aric Parnes, Jean M. Connors, Nathan T. Connell, Marie N. Discenza, Robert I. Handin, Nancy Berliner, Akiko Shimamura, Elizabeth S. Ginsburg, Nicole A. Smith

Blood (2017) 130 (14): 1671–1674.

https://doi.org/10.1182/blood-2017-08-798462

Published: 2017

Journal Articles

HIT the price point with fondaparinux

Nathan T. Connell

Blood (2016) 128 (26): 3019–3020.

https://doi.org/10.1182/blood-2016-11-750513

Published: 2016

Journal Articles

Which ’roid is all the rage?

Nathan T. Connell, Nancy Berliner

Blood (2016) 127 (3): 273.

https://doi.org/10.1182/blood-2015-11-678854

Published: 2016

Journal Articles

Cost-Effectiveness Analysis of Warfarin Versus Low-Molecular Weight Heparin for the Treatment of Malignancy-Associated Venous Thromboembolism

Nathan T. Connell, MD, M.P.H., Gregory A. Abel, MD MPH, Jean M. Connors, MD

Blood (2015) 126 (23): 746.

https://doi.org/10.1182/blood.V126.23.746.746

Published: 2015

Journal Articles

The role of hematologists in a changing United States health care system

Paul J. Wallace, Nathan T. Connell, Janis L. Abkowitz

Blood (2015) 125 (16): 2467–2470.

https://doi.org/10.1182/blood-2014-12-615047

Published: 2015

Journal Articles

Correlation Of ADAMTS13 Activity With Baseline Characteristics and Management Patterns In Patients With Suspected Thrombotic Thrombocytopenic Purpura In The State Of Rhode Island

Nathan T. Connell, MD, Joseph D. Sweeney, MD

Blood (2013) 122 (21): 3556.

https://doi.org/10.1182/blood.V122.21.3556.3556

Published: 2013

NARROW

An evolving understanding of low VWF and type 1 VWD

Factor XIII subunits are stronger together

Avatrombopag for Adults with Early Versus Chronic Immune Thrombocytopenia

Evaluating the Impact of a Year-Long External Mentorship Pilot Program in Classical Hematology

Real-World Analysis of Healthcare Resource Utilization and Costs Among Patients Diagnosed with Von Willebrand Disease and Angiodysplasia

Diversity, Equity, and Inclusion in Hematology and Oncology Fellowship Programs

Anticoagulation Use and Outcomes Among Patients with Atrial Fibrillation and Von Willebrand Disease

Cost-Effectiveness of Long-Term Prophylaxis Versus on-Demand Treatment with Von Willebrand Factor Concentrate in Severe Inherited Von Willebrand Disease

Treatment of Acquired Hemophilia a with Rituximab and Emicizumab

Taken the wrong way, a complement becomes catastrophic

Mentorship Experiences Among Second-Year U.S. Hematology/Oncology Fellows in the 2019 ASH Hematology/Oncology Fellows Survey

Pregnancy Outcomes, Risk Factors, and Gestational Cell Count Trends in Pregnant Women with Essential Thrombocythemia and Polycythemia Vera

Fostamatinib for the treatment of chronic immune thrombocytopenia

Ravulizumab: a complementary option for PNH

Pregnancy outcomes in inherited bone marrow failure syndromes

HIT the price point with fondaparinux

Which ’roid is all the rage?

Cost-Effectiveness Analysis of Warfarin Versus Low-Molecular Weight Heparin for the Treatment of Malignancy-Associated Venous Thromboembolism

The role of hematologists in a changing United States health care system

Correlation Of ADAMTS13 Activity With Baseline Characteristics and Management Patterns In Patients With Suspected Thrombotic Thrombocytopenic Purpura In The State Of Rhode Island

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only